1. ScholarBank@NUS
  2. Research Outputs

Browsing by Author WANG LINGZHI

Select a letter below to browse by last name or type
0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z


Showing results 35 to 54 of 55 < previous   next >
Issue DateTitleAuthor(s)
2018Pan-CDK inhibition augments cisplatin lethality in nasopharyngeal carcinoma cell lines and xenograft modelsSyn N.L.; Lim P.L.; Kong L.R.; Wang L. ; Wong A.L.-A. ; Lim C.M. ; Loh T.K.S. ; Siemeister G.; Goh B.C. ; Hsieh W.-S. 
28-Mar-2018Pan-HDAC inhibition by panobinostat mediates chemosensitization to carboplatin in non-small cell lung cancer via attenuation of EGFR signalingWang, Lingzhi ; Syn, Nicholas Li-Xun; Subhash, Vinod Vijay; Any, Yijia; Thuya, Win Lwin ; Cheow, Esther Sok Hwee ; Kong, Li Ren ; Yu, Fenggang ; Peethala, Praveen C. ; Wong, Andrea Li-Ann ; Laljibhai, Hirpara J. ; Chinnathambi, Arunachalam; Ong, Pei Shi ; Ho, Paul Chi-Lui ; Sethi, Gautam ; Yong, Wei Peng ; Goh, Boon Cher 
Sep-2011Pharmacokinetic modeling of plasma and intracellular concentrations of raltegravir in healthy volunteersWang, L. ; Soon, G.H.; Seng, K.-Y.; Li, J.; Lee, E.; Yong, E.-L.; Goh, B.-C.; Flexner, C.; Lee, L.
2015Phase I and biomarker study of OPB-51602, a novel signal transducer and activator of transcription (STAT) 3 inhibitor, in patients with refractory solid malignanciesWong, Andrea; Soo, Ross A.; Tan, Daniel; Lee, Soo Chin ; Lim, Joline S J; Marban, P.C.; Kong, Li Ren ; Lee, Youngjoo; Wang, Lingzhi ; Thuya, Win Lwin ; Soong, R.; Yee, M.Q.; Chin, T.M.; Cordero, Maricel Tiemsim; Asuncion, Bernadette Reyna ; Pang, B.; Pervaiz, Shazib ; Hirpara, Jayshree L. ; Sinha, Arvind; Xu, W.W.; Yuasa, M.; Tsunoda, T.; Motoyama, M.; Yamauchi, T.; Goh, Boon Cher 
1-Aug-2003Phase I trial of fixed dose-rate gemcitabine in combination with carboplatin in chemonaive advanced non-small-cell lung cancer: A Cancer Therapeutics Research Group studySoo, R.A. ; Lim, H.L.; Wang, L.Z. ; Lee, H.S.; Millward, M.J.; Tok, L.T.; Lee, S.C. ; Lehnert, M.; Goh, B.C.
2016Phase Ib/II randomized, open-label study of doxorubicin and cyclophosphamide with or without low-dose, short-course sunitinib in the pre-operative treatment of breast cancerWong A.L.A. ; Sundar R.; Wang T.-T. ; Ng T.-C. ; Zhang B. ; Tan S.-H. ; Soh T.I.P.; Pang A.S.L.; Tan C.-S.; Ow S.G.W.; Wang L. ; Mogro J.; Ho J.; Jeyasekharan A.D. ; Huang Y.; Thng C.-H. ; Chan C.-W. ; Hartman M. ; Iau P.; Buhari S.A. ; Goh B.-C. ; Lee S.-C. 
2001Phenolic compounds of Chromolaena adorata protect cultured skin cells from oxidative damage: Implication for cutaneous wound healingPhan, T.-T.; Wang, L. ; See, P.; Grayer, R.J.; Chan, S.-Y. ; Lee, S.T.
1-Mar-2003Phenotyping CYP3A using midazolam in cancer and noncancer Asian patientsLee, H.S.; Goh, B.C.; Fan, L.; Khoo, Y.M.; Wang, L. ; Lim, R.; Ong, A.B.; Chua, C.
Apr-2008PXR, CAR and HNF4α genotypes and their association with pharmacokinetics and pharmacodynamics of docetaxel and doxorubicin in Asian patientsHor, S.Y.; Lee, S.C. ; Wong, C.I.; Lim, Y.W.; Lim, R.C.; Wang, L.Z. ; Fan, L.; Guo, J.Y. ; Lee, H.S.; Goh, B.C.; Tan, T. 
Mar-2013Quantification of L-ergothioneine in human plasma and erythrocytes by liquid chromatography-tandem mass spectrometryWang, L.-Z. ; Thuya, W.-L. ; Toh, D.S.-L.; Lie, M.G.-L.; Lau, J.-Y.A.; Kong, L.-R.; Wan, S.-C.; Chua, K.-N.; Lee, E.J.-D.; Goh, B.-C.
26-Feb-2003Quantitation of paclitaxel in micro-sample rat plasma by a sensitive reversed-phase HPLC assayWang, L.Z. ; Ho, P.C. ; Lee, H.S.; Vaddi, H.K.; Chan, Y.W.; Yung, C.S. 
15-Jul-2011Rapid determination of gefitinib and its main metabolite, O-desmethyl gefitinib in human plasma using liquid chromatography-tandem mass spectrometryWang, L.-Z. ; Lim, M.Y.-X.; Chin, T.-M. ; Thuya, W.-L. ; Nye, P.-L.; Wong, A.; Chan, S.-Y. ; Goh, B.-C.; Ho, P.C. 
2009Rapid determination of gemcitabine and its metabolite in human plasma by LC-MSMS through micro protein precipitation with minimum matrix effectWang, L.-Z. ; Yong, W.-P. ; Soo, R.-A. ; Lee, S.-C. ; Soong, R. ; Lee, H.-S.; Goh, B.-C.
2018Role of novel histone modifications in cancerShanmugam, M.K ; Arfuso, F; Arumugam, S; Chinnathambi, A; Jinsong, B ; Warrier, S; Wang, L.Z ; Kumar, A.P ; Ahn, K.S; Sethi, G ; Lakshmanan, M
2004Sensitive high-performance liquid chromatography/mass spectrometry method for determination of steviol in rat plasmaWang, L.Z. ; Goh, B.C.; Fan, L.; Lee, H.S.
Feb-2011Simultaneous determination of raltegravir and raltegravir glucuronide in human plasma by liquid chromatography-tandem mass spectrometric methodWang, L.-Z. ; Lee, L.S.-U.; Thuya, W.-L. ; Soon, G.H.; Kong, L.-R.; Nye, P.-L.; Deoon Lee, E.J.; Flexner, C.; Goh, B.-C.
2018Sorcin a Potential Molecular Target for Cancer TherapyShabnam B.; Padmavathi G.; Banik K.; Girisa S.; Monisha J.; Sethi G. ; Fan L.; Wang L. ; Mao X.; Kunnumakkara A.B.
29-Apr-2020Targeting codon 158 p53-mutant cancers via the induction of p53 acetylationKong, Li Ren ; Ong, Richard Weijie; Tan, Tuan Zea ; Salleh, Nur Afiqah Binte Mohamed ; Thangavelu, Matan; Chan, Jane Vin; Koh, Lie Yong Judice; Periyasamy, Giridharan; Lau, Jieying Amelia ; Le, Thi Bich Uyen; Wang, Lingzhi ; Lee, Miyoung; Kannan, Srinivasaraghavan; Verma, Chandra S ; Lim, Chwee Ming ; Chng, Wee Joo ; Lane, David P ; Venkitaraman, Ashok ; Hung, Huynh The; Cheok, Chit Fang ; Goh, Boon Cher 
2019Targeting STAT3 and oxidative phosphorylation in oncogene-addicted tumorsLee M.; Hirpara J.L. ; Eu J.-Q. ; Sethi G. ; Wang L. ; Goh B.-C. ; Wong A.L. 
2018TIPE family of proteins and its implications in different chronic diseasesBordoloi D.; Banik K.; Shabnam B.; Padmavathi G.; Monisha J.; Arfuso F.; Dharmarajan A.; Mao X., Lim L.H.K. ; Wang L. ; Fan L. ; Hui K.M. ; Kumar A.P. ; Sethi G. ; Kunnumakkara A.B.
Showing results 35 to 54 of 55 < previous   next >